Coya Therapeutics, Inc. (COYA)

NASDAQ: COYA · Real-Time Price · USD

4.400

-0.100 (-2.22%)

At close: Mar 17, 2026, 4:00 PM EDT

4.400

0.00 (0.00%)

After-hours: Mar 17, 2026, 4:10 PM EDT

Coya Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	46.82	38.34	32.63	5.93	4.34
Cash & Short-Term Investments	46.82	38.34	32.63	5.93	4.34
Cash Growth	22.13%	17.51%	449.85%	36.72%	-
Accounts Receivable	-	-	7.5	-	-
Other Current Assets	3.12	5.97	1.07	1.25	0.24
Total Current Assets	49.94	44.31	41.2	7.18	4.58
Net Property, Plant & Equipment	0.01	0.04	0.07	0.09	0.12
Other Long-Term Assets	-	-	-	1.12	0.09
Total Assets	49.95	44.35	41.26	8.4	4.79
Accounts Payable	1.06	1.59	1.16	1.82	0.86
Accrued Expenses	3.61	1.39	2.97	2.01	0.29
Unearned Revenue	1.2	0.85	0.92	-	-
Total Current Liabilities	5.87	3.82	5.05	3.82	1.15
Long-Term Debt	-	-	-	12.97	-
Other Long-Term Liabilities	1.05	0.95	0.57	-	-
Total Long-Term Liabilities	1.05	0.95	0.57	12.97	-
Total Liabilities	6.92	4.77	5.63	16.79	1.15
Preferred Stock	-	-	-	8.79	8.79
Common Stock	0	0	0	0	0
Additional Paid-in Capital	104.99	80.31	61.49	0.68	0.47
Retained Earnings	-61.96	-40.74	-25.86	-17.87	-5.62
Shareholders' Equity	43.03	39.58	35.64	-8.39	3.64
Total Liabilities & Equity	49.95	44.35	41.26	8.4	4.79
Total Debt	0	0	0	12.97	0
Net Cash (Debt)	46.82	38.34	32.63	-7.03	4.34
Net Cash Growth	22.13%	17.51%	-	-	-
Net Cash Per Share	2.80	2.52	3.21	-2.71	1.68
Book Value	43.03	39.58	35.64	-8.39	3.64
Book Value Per Share	2.57	2.60	3.51	-3.24	1.41
Tangible Book Value	43.03	39.58	35.64	-8.39	3.64
Tangible Book Value Per Share	2.57	2.60	3.51	-3.24	1.41

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q